AAPL342.92-0.55 (-0.16%) ▼|ABBV284.42-1.00 (-0.35%) ▼|ABT104.32-0.57 (-0.54%) ▼|ACN235.20+5.52 (+2.40%) ▲|ADBE246.56+1.36 (+0.55%) ▲|AMAT417.31+8.02 (+1.96%) ▲|AMD539.43+10.68 (+2.02%) ▲|AMGN428.11-4.39 (-1.01%) ▼|AMT182.00-3.28 (-1.77%) ▼|AMZN262.08+12.08 (+4.83%) ▲|AVGO335.37+6.62 (+2.01%) ▲|AXP315.88+2.29 (+0.73%) ▲|BA191.26+1.05 (+0.55%) ▲|BAC50.45-0.78 (-1.52%) ▼|BKNG161.95-1.50 (-0.92%) ▼|BLK1,125.72-8.66 (-0.76%) ▼|BMY59.10-0.65 (-1.09%) ▼|BNY143.18-0.12 (-0.08%) ▼|BRK-B532.48+0.46 (+0.09%) ▲|C122.37-1.89 (-1.52%) ▼|CAT727.56-3.20 (-0.44%) ▼|CL93.49-0.62 (-0.66%) ▼|CMCSA22.03+0.13 (+0.59%) ▲|COF199.96-1.78 (-0.88%) ▼|COP145.42-1.09 (-0.74%) ▼|COST995.54+6.43 (+0.65%) ▲|CRM242.31+1.61 (+0.67%) ▲|CSCO107.09-0.30 (-0.28%) ▼|CVS91.62-0.74 (-0.80%) ▼|CVX224.99-0.01 (0.00%) ▼|DE629.09-12.77 (-1.99%) ▼|DHR224.75-4.30 (-1.88%) ▼|DIS109.89-0.70 (-0.63%) ▼|DUK119.75-1.72 (-1.42%) ▼|EMR160.78-0.69 (-0.43%) ▼|FDX292.70-0.85 (-0.29%) ▼|GD342.86-1.38 (-0.40%) ▼|GE312.88-0.95 (-0.30%) ▼|GEV911.55-9.65 (-1.05%) ▼|GILD154.70-1.49 (-0.95%) ▼|GM82.61-1.35 (-1.61%) ▼|GOOG340.22+3.31 (+0.98%) ▲|GOOGL344.34+3.75 (+1.10%) ▲|GS875.52-5.74 (-0.65%) ▼|HD310.46+0.83 (+0.27%) ▲|HON210.47-0.95 (-0.45%) ▼|IBM236.90+4.76 (+2.05%) ▲|INTC92.51+2.66 (+2.96%) ▲|INTU325.96+0.81 (+0.25%) ▲|ISRG433.05+6.35 (+1.49%) ▲|JNJ254.24-1.33 (-0.52%) ▼|JPM334.90-4.83 (-1.42%) ▼|KO93.87-0.03 (-0.03%) ▼|LIN504.07+5.64 (+1.13%) ▲|LLY1,251.71-5.32 (-0.42%) ▼|LMT553.09+1.00 (+0.18%) ▲|LOW196.35-1.03 (-0.52%) ▼|LRCX274.09+10.15 (+3.84%) ▲|MA615.72-1.70 (-0.28%) ▼|MCD243.09+0.12 (+0.05%) ▲|MDLZ63.56-0.35 (-0.55%) ▼|MDT93.08-1.67 (-1.76%) ▼|META702.62-6.71 (-0.95%) ▼|MMM163.13-1.63 (-0.99%) ▼|MO74.79-0.32 (-0.43%) ▼|MRK144.48-1.47 (-1.01%) ▼|MS179.14-1.43 (-0.79%) ▼|MSFT534.16+5.11 (+0.97%) ▲|MU905.25+26.41 (+3.00%) ▲|NEE78.35-1.46 (-1.82%) ▼|NFLX69.52-1.01 (-1.43%) ▼|NKE37.11-0.03 (-0.07%) ▼|NOW144.64+2.67 (+1.88%) ▲|NVDA217.40+3.27 (+1.53%) ▲|ORCL130.04+1.81 (+1.41%) ▲|PEP133.22+1.73 (+1.32%) ▲|PFE29.47-0.12 (-0.39%) ▼|PG158.19-1.16 (-0.73%) ▼|PLTR194.27+8.24 (+4.43%) ▲|PM202.88-2.33 (-1.13%) ▼|QCOM173.54+1.43 (+0.83%) ▲|RTX193.17-0.75 (-0.39%) ▼|SBUX98.10+0.58 (+0.59%) ▲|SCHW89.99-1.97 (-2.14%) ▼|SO89.81-1.37 (-1.50%) ▼|SPG202.59-2.85 (-1.39%) ▼|T23.34-0.11 (-0.45%) ▼|TMO679.81-10.19 (-1.48%) ▼|TMUS157.88-1.22 (-0.77%) ▼|TSLA368.00+13.28 (+3.74%) ▲|TXN276.41-0.08 (-0.03%) ▼|UBER70.33-0.03 (-0.04%) ▼|UNH405.18+3.75 (+0.93%) ▲|UNP287.87-1.17 (-0.40%) ▼|UPS97.15-0.33 (-0.34%) ▼|USB58.17-0.57 (-0.96%) ▼|V403.61+1.00 (+0.25%) ▲|VZ44.38-0.41 (-0.92%) ▼|WFC82.48-1.39 (-1.66%) ▼|WMT119.22+0.41 (+0.34%) ▲|XOM178.67-0.31 (-0.17%) ▼|AAPL342.92-0.55 (-0.16%) ▼|ABBV284.42-1.00 (-0.35%) ▼|ABT104.32-0.57 (-0.54%) ▼|ACN235.20+5.52 (+2.40%) ▲|ADBE246.56+1.36 (+0.55%) ▲|AMAT417.31+8.02 (+1.96%) ▲|AMD539.43+10.68 (+2.02%) ▲|AMGN428.11-4.39 (-1.01%) ▼|AMT182.00-3.28 (-1.77%) ▼|AMZN262.08+12.08 (+4.83%) ▲|AVGO335.37+6.62 (+2.01%) ▲|AXP315.88+2.29 (+0.73%) ▲|BA191.26+1.05 (+0.55%) ▲|BAC50.45-0.78 (-1.52%) ▼|BKNG161.95-1.50 (-0.92%) ▼|BLK1,125.72-8.66 (-0.76%) ▼|BMY59.10-0.65 (-1.09%) ▼|BNY143.18-0.12 (-0.08%) ▼|BRK-B532.48+0.46 (+0.09%) ▲|C122.37-1.89 (-1.52%) ▼|CAT727.56-3.20 (-0.44%) ▼|CL93.49-0.62 (-0.66%) ▼|CMCSA22.03+0.13 (+0.59%) ▲|COF199.96-1.78 (-0.88%) ▼|COP145.42-1.09 (-0.74%) ▼|COST995.54+6.43 (+0.65%) ▲|CRM242.31+1.61 (+0.67%) ▲|CSCO107.09-0.30 (-0.28%) ▼|CVS91.62-0.74 (-0.80%) ▼|CVX224.99-0.01 (0.00%) ▼|DE629.09-12.77 (-1.99%) ▼|DHR224.75-4.30 (-1.88%) ▼|DIS109.89-0.70 (-0.63%) ▼|DUK119.75-1.72 (-1.42%) ▼|EMR160.78-0.69 (-0.43%) ▼|FDX292.70-0.85 (-0.29%) ▼|GD342.86-1.38 (-0.40%) ▼|GE312.88-0.95 (-0.30%) ▼|GEV911.55-9.65 (-1.05%) ▼|GILD154.70-1.49 (-0.95%) ▼|GM82.61-1.35 (-1.61%) ▼|GOOG340.22+3.31 (+0.98%) ▲|GOOGL344.34+3.75 (+1.10%) ▲|GS875.52-5.74 (-0.65%) ▼|HD310.46+0.83 (+0.27%) ▲|HON210.47-0.95 (-0.45%) ▼|IBM236.90+4.76 (+2.05%) ▲|INTC92.51+2.66 (+2.96%) ▲|INTU325.96+0.81 (+0.25%) ▲|ISRG433.05+6.35 (+1.49%) ▲|JNJ254.24-1.33 (-0.52%) ▼|JPM334.90-4.83 (-1.42%) ▼|KO93.87-0.03 (-0.03%) ▼|LIN504.07+5.64 (+1.13%) ▲|LLY1,251.71-5.32 (-0.42%) ▼|LMT553.09+1.00 (+0.18%) ▲|LOW196.35-1.03 (-0.52%) ▼|LRCX274.09+10.15 (+3.84%) ▲|MA615.72-1.70 (-0.28%) ▼|MCD243.09+0.12 (+0.05%) ▲|MDLZ63.56-0.35 (-0.55%) ▼|MDT93.08-1.67 (-1.76%) ▼|META702.62-6.71 (-0.95%) ▼|MMM163.13-1.63 (-0.99%) ▼|MO74.79-0.32 (-0.43%) ▼|MRK144.48-1.47 (-1.01%) ▼|MS179.14-1.43 (-0.79%) ▼|MSFT534.16+5.11 (+0.97%) ▲|MU905.25+26.41 (+3.00%) ▲|NEE78.35-1.46 (-1.82%) ▼|NFLX69.52-1.01 (-1.43%) ▼|NKE37.11-0.03 (-0.07%) ▼|NOW144.64+2.67 (+1.88%) ▲|NVDA217.40+3.27 (+1.53%) ▲|ORCL130.04+1.81 (+1.41%) ▲|PEP133.22+1.73 (+1.32%) ▲|PFE29.47-0.12 (-0.39%) ▼|PG158.19-1.16 (-0.73%) ▼|PLTR194.27+8.24 (+4.43%) ▲|PM202.88-2.33 (-1.13%) ▼|QCOM173.54+1.43 (+0.83%) ▲|RTX193.17-0.75 (-0.39%) ▼|SBUX98.10+0.58 (+0.59%) ▲|SCHW89.99-1.97 (-2.14%) ▼|SO89.81-1.37 (-1.50%) ▼|SPG202.59-2.85 (-1.39%) ▼|T23.34-0.11 (-0.45%) ▼|TMO679.81-10.19 (-1.48%) ▼|TMUS157.88-1.22 (-0.77%) ▼|TSLA368.00+13.28 (+3.74%) ▲|TXN276.41-0.08 (-0.03%) ▼|UBER70.33-0.03 (-0.04%) ▼|UNH405.18+3.75 (+0.93%) ▲|UNP287.87-1.17 (-0.40%) ▼|UPS97.15-0.33 (-0.34%) ▼|USB58.17-0.57 (-0.96%) ▼|V403.61+1.00 (+0.25%) ▲|VZ44.38-0.41 (-0.92%) ▼|WFC82.48-1.39 (-1.66%) ▼|WMT119.22+0.41 (+0.34%) ▲|XOM178.67-0.31 (-0.17%) ▼|
15.1 C
New York
Monday, October 19, 2026

Tag: medicine

newssourceFORcompanycontentinformation1releasesmarket

FIU study points the way to building mental toughness and enjoying exercise

MIAMI, July 8, 2025 /PRNewswire/ -- Struggling to start a workout routine or stick with one? New research offers a surprising insight: your brain, not...

New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model

Medium and high doses improved movement quality in up to 100% of the animals in a dose-dependent manner 
Medium and high doses improved movement quality in up to 100% of the animals in a dose-dependent manner

Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine into Clinic and Expand Universal Immunity Portfolio

Oversubscribed round was led by Future Ventures, and included NFX, BOLD Capital Partners, Kendall Capital Partners, Amplify Partners, Base4 Capital and others Dr. Emilio Emini, former SVP of...

Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025

CARLSBAD, Calif., July 8, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities...

Phoenix Children’s Names John R. Nickens IV as President & CEO

PHOENIX, July 8, 2025 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric healthcare systems, today announced the appointment of John R. Nickens IV...

Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare

Transforming Healthcare Ltd Unveils the Healthcare Convergence Framework® AI/Robotics Self-Assessment Scorecard 
Transforming Healthcare Ltd Unveils the Healthcare Convergence Framework® AI/Robotics Self-Assessment Scorecard

Allegheny Health Network appoints two leaders to key executive roles

New chief operating officer, chief quality officer added to core AHN c-suite team led by recently appointed president Mark Sevco PITTSBURGH, July 8, 2025 /PRNewswire/...

From Stem Cells to CAR-T: LivMedCell Expands Its Role in the Future of Medicine

LivMedCell is Turkey’s first hospital-based stem cell production center operating under GMP standards, located within Liv Hospital in Istanbul.

Biotia Partners with Leading Korean Pharmaceutical Company to Advance Infectious Disease Diagnostics in Remote Regions — Including in Space

QUEENS, N.Y., July 8, 2025 /PRNewswire/ -- Biotia, a biotechnology company pioneering the development of novel infectious disease diagnostics, today announced its selection as...

HealthBook+ Launches PaiGE™, a Groundbreaking AI Health Assistant Bridging the Gap Between Patient Visits

All-in-one, intelligent healthcare platform empowers patients and clinicians with instant insights, tailored support, and streamlined care. DENVER, July 8, 2025 /PRNewswire/ -- HealthBook+, a leader in...

Mercy BioAnalytics Appoints Dr. Prasanth Reddy as Chief Medical Officer

WALTHAM, Mass., July 8, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today...

Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy...

FDA approves Longeveron's Investigational New Drug (IND) application for stem cell therapy as a potential treatment for pediatric dilated cardiomyopathy.

Zuellig Pharma Launches “Obesity is a Disease” Seminar as Part of “Reduce Size, Reduce Disease” Campaign

The campaign aims to enhance the understanding of obesity as a chronic disease and solutions to help manage the disease among Thais and healthcare...

Novartis receives approval for first malaria medicine for newborn babies and young infants

Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedicine

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers